|
C16ORF70 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.574550E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.037800E-01 |
| Normal-vs-Stage2 |
3.257800E-02 |
| Normal-vs-Stage3 |
1.262360E-01 |
| Normal-vs-Stage4 |
5.104200E-01 |
| Stage1-vs-Stage2 |
4.031700E-02 |
| Stage1-vs-Stage3 |
1.444570E-01 |
| Stage1-vs-Stage4 |
4.386600E-01 |
| Stage2-vs-Stage3 |
8.404800E-01 |
| Stage2-vs-Stage4 |
6.852500E-02 |
| Stage3-vs-Stage4 |
2.104200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.376600E-01 |
| Normal-vs-AfricanAmerican |
3.706800E-01 |
| Normal-vs-Asian |
3.501800E-01 |
| Caucasian-vs-AfricanAmerican |
9.506400E-01 |
| Caucasian-vs-Asian |
4.008400E-01 |
| AfricanAmerican-vs-Asian |
3.992400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.315650E-01 |
| Normal-vs-Female |
4.107000E-01 |
| Male-vs-Female |
5.533000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.443400E-01 |
| Normal-vs-Extreme_Weight |
9.124200E-01 |
| Normal-vs-Obese |
1.925970E-01 |
| Normal-vs-Extreme_Obese |
7.413200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.628200E-01 |
| Normal_Weight-vs-Obese |
6.620500E-02 |
| Normal_Weight-vs-Extreme_Obese |
5.064000E-01 |
| Extreme_Weight-vs-Obese |
1.532230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.773600E-01 |
| Obese-vs-Extreme_Obese |
6.534600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.132400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.235400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.808980E-01 |
| Normal-vs-Age(81-100Yrs) |
7.868600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.863800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.915200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.524400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.687400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.893000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.934390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.793840E-01 |
| Normal-VS-Type2 PRCC |
2.307600E-01 |
| Normal-VS-KIRP CIMP |
9.910300E-02 |
| Normal-VS-Unclassified PRCC |
1.081890E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.036000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.987510E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.399700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.657690E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.485400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.198300E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.436370E-01 |
| Normal-vs-N1 |
3.938400E-01 |
| Normal-vs-N2 |
4.074400E-02 |
| N0-vs-N1 |
4.554000E-01 |
| N0-vs-N2 |
1.538990E-01 |
| N1-vs-N2 |
2.932400E-02 |
|
|
